These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

807 related articles for article (PubMed ID: 32367431)

  • 1. Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain.
    Li Z; Liu T; Yang N; Han D; Mi X; Li Y; Liu K; Vuylsteke A; Xiang H; Guo X
    Front Med; 2020 Oct; 14(5):533-541. PubMed ID: 32367431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
    Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
    Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropathogenic human coronaviruses: A review.
    Abdelaziz OS; Waffa Z
    Rev Med Virol; 2020 Sep; 30(5):e2118. PubMed ID: 32687681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on neurological manifestations of COVID-19.
    Yavarpour-Bali H; Ghasemi-Kasman M
    Life Sci; 2020 Sep; 257():118063. PubMed ID: 32652139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updates on What ACS Reported: Emerging Evidences of COVID-19 with Nervous System Involvement.
    Baig AM
    ACS Chem Neurosci; 2020 May; 11(9):1204-1205. PubMed ID: 32343122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Relevance.
    Achar A; Ghosh C
    Cells; 2020 Oct; 9(11):. PubMed ID: 33120941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neurological damage linked to coronaviruses : SARS-CoV-2 and other human coronaviruses].
    Salinas S; Simonin Y
    Med Sci (Paris); 2020; 36(8-9):775-782. PubMed ID: 32755537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Insights into Immune Responses during COVID-19.
    St John AL; Rathore APS
    J Immunol; 2020 Aug; 205(3):555-564. PubMed ID: 32513850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.
    Kempuraj D; Selvakumar GP; Ahmed ME; Raikwar SP; Thangavel R; Khan A; Zaheer SA; Iyer SS; Burton C; James D; Zaheer A
    Neuroscientist; 2020; 26(5-6):402-414. PubMed ID: 32684080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrum of Neurological Manifestations in Covid-19: A Review.
    Garg RK
    Neurol India; 2020; 68(3):560-572. PubMed ID: 32643664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
    Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
    J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurological manifestations in COVID-19 caused by SARS-CoV-2.
    Baig AM
    CNS Neurosci Ther; 2020 May; 26(5):499-501. PubMed ID: 32266761
    [No Abstract]   [Full Text] [Related]  

  • 13. The trinity of COVID-19: immunity, inflammation and intervention.
    Tay MZ; Poh CM; Rénia L; MacAry PA; Ng LFP
    Nat Rev Immunol; 2020 Jun; 20(6):363-374. PubMed ID: 32346093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neurological aspects of the COVID-19 pandemic caused by the SARS-CoV-2 coronavirus].
    Bereczki D; Stang R; Böjti P; Kovács T
    Ideggyogy Sz; 2020 May; 73(05-06):171-175. PubMed ID: 32579306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronaviruses and gastrointestinal diseases.
    Luo X; Zhou GZ; Zhang Y; Peng LH; Zou LP; Yang YS
    Mil Med Res; 2020 Oct; 7(1):49. PubMed ID: 33054860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 and SARS-Cov-2 Infection: Pathophysiology and Clinical Effects on the Nervous System.
    Abboud H; Abboud FZ; Kharbouch H; Arkha Y; El Abbadi N; El Ouahabi A
    World Neurosurg; 2020 Aug; 140():49-53. PubMed ID: 32474093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential neurological impact of coronaviruses: implications for the novel SARS-CoV-2.
    Iroegbu JD; Ifenatuoha CW; Ijomone OM
    Neurol Sci; 2020 Jun; 41(6):1329-1337. PubMed ID: 32424503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19: Are we dealing with a multisystem vasculopathy in disguise of a viral infection?
    Mondal R; Lahiri D; Deb S; Bandyopadhyay D; Shome G; Sarkar S; Paria SR; Thakurta TG; Singla P; Biswas SC
    J Thromb Thrombolysis; 2020 Oct; 50(3):567-579. PubMed ID: 32627126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 pandemic, coronaviruses, and diabetes mellitus.
    Muniyappa R; Gubbi S
    Am J Physiol Endocrinol Metab; 2020 May; 318(5):E736-E741. PubMed ID: 32228322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotropism of SARS-CoV 2: Mechanisms and manifestations.
    Conde Cardona G; Quintana Pájaro LD; Quintero Marzola ID; Ramos Villegas Y; Moscote Salazar LR
    J Neurol Sci; 2020 May; 412():116824. PubMed ID: 32299010
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 41.